Skip to content
Search

Latest Stories

Online pharmacy PillTime installs Titan PMR in its new state-of-art facility to boost prescription growth

Online pharmacy PillTime has taken a step to boost its prescription growth by implementing new Patient Medication Record (PMR) system Titan in its state-of-the-art premises.

PillTime moved to new, expanded 26,000sqft premises in Cribbs Causeway on the edge of Bristol earlier this year, where it has also installed state-of-the-art robotics in a bid to significantly enhance future productivity and capacity.


Teething problems over Easter weekend saw PillTime struggling to seamlessly integrate all the new systems and processes while physically moving premises which affected service delivery and customer support.

However, CEO Leighton Humphreys was supported by Tariq Muhammad, CEO of Invatech Health, who is a former community pharmacist and has worked with independent pharmacies around the UK as well as larger online businesses, to integrate Titan into their workflows.

Alongside integration work, Muhammad and his team supported PillTime with necessary design, governance and pharmacy expertise as the company struggled to meet its usual high standards for dispensing medicines to patients.

“We had ambitious plans for our move but things turned out to be more complicated than we had envisaged,” said Humphreys. “So we are extremely grateful to Tariq and his team of pharmacists for the support they provided.

“We thank our customers for sticking with us during this challenging period for our business and we’re looking ahead now. Titan will make a major difference to how we operate and grow, alongside the cutting-edge robotics and innovative pouching system which are unique at this scale.”

Founded in 2016, PillTime currently provides prescription medicines in daily dosage pouches to around 11,000 NHS patients across the UK.

Following the deployment of Titan, it forecasts 900 per cent growth in the next two to three years. It hopes to hit the 100,000 patient mark by the end of 2023 – a figure it says is still ‘only a drop in the ocean’.

Last year Invatech Health announced a further £950,000 loan from Innovate UK, under a programme to support game-changing innovations in the UK’s SME community.

Muhammad, said he was pleased to support PillTime.

“Having established our systems in the community pharmacy sector, we are now enjoying rolling out Titan Enterprise to innovative online pharmacy businesses,” he said, adding: “We’re helping them process prescriptions safely at a speed which is unheard of until now.

“Of course It’s great to be collaborating with another innovative Bristol-based business which is looking to help transform the way that people manage and access their medication.

“Now all systems are fully operational, we are excited to see how PillTime develops over the coming months and years.”

Humphreys said that PillTime’s offering of medication in easy-to-understand pouches provided a solution to several problems, from reducing the requirement for carers and nursing homes, while minimising hospital admissions through medication errors.

“There are far too many instances of medications being properly dispensed but incorrectly taken, leading to people not getting better as they should do,” he said.

“In some parts of the world the pouching system has become standard because it’s foolproof, as long as the patient is fully aware. We want that to happen here, too. Our mission is cost savings to the NHS and a better quality of convenience and level of healthcare. “

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less